Skip to main content
High RiskFDAfda-F-1346-2013UNDECLARED ALLERGEN

Jasmine Brand Garlic Flavored Crackers (Krupuk Bawang), 40x250gr.

Units Affected
75
Recall Date
March 1, 2013
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2013.

Wira Corp. is recalling Jasmine Garlic Flavored Crackers because of undeclared colors FD& C Blue#1, FD & C Yellow # 5 , FD&C Yellow #6 and unapproved food color ingredients Ponceau 4R, E124, (Acid Red 18).

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Jans Enterprises Corp. Dba Wira Corp. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2013.

Jans Enterprises Corp. dba WIRA Corp.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Jans Enterprises Corp. Dba Wira Corp. Recall FAQ

Jans Enterprises Corp. Dba Wira Corp. is the subject of a bakery & grains safety report: Jasmine Brand Garlic Flavored Crackers (Krupuk Bawang), 40x250gr.. The notice was published on March 1, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 75 units are potentially affected.